Johnson and Johnson (JNJ)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Johnson & Johnson Reveals Strategy for Long-Term Growth in the Healthcare Industry
Johnson & Johnson Appoints Eugene A Woods as New Board Member Amidst Declining Stock Performance
Johnson & Johnson Declares Quarterly Dividend Amidst Declining Stock Performance
Johnson & Johnson Reports Strong Q3 2023 Results, Advances in Pipeline, Despite Recent Stock Dip
Major Pharmaceutical Company Sees Impressive 26.45% Earnings Jump in Q4 20232.
Insignificant dip in the Top-line at the company in the November to January 01 2023 span
EPS Soared by 22.63 % with a reasonable effort in the November to January 02 2022 interval